Clinical Report: Is remote robotic subretinal injection feasible?

Background

Submacular hemorrhage can lead to significant vision loss, and timely intervention is crucial for optimal outcomes. Traditional methods of treatment often require direct surgeon involvement, which can be limited by geographical constraints.

Data Highlights

Key Findings

• The remote robotic injection was successfully completed without intraoperative complications.
• No serious adverse events occurred during the 3-month follow-up period.
• Progressive resolution of submacular hemorrhage was observed, with complete resolution by postoperative day 23.
• Despite anatomical improvement, there was no change in best-corrected visual acuity (BCVA) at 3 months.
• The study highlights the need for larger multicenter studies to evaluate safety and efficacy.

Clinical Implications

The findings suggest that remote robotic-assisted subretinal injection is technically feasible and safe, potentially expanding treatment access for patients with submacular hemorrhage. However, the lack of improvement in visual acuity despite anatomical resolution indicates the need for timely intervention.

Conclusion

This case study demonstrates the feasibility of remote robotic subretinal injection.

Related Resources & Content

1. Xu A., JAMA Ophthalmology, 2026 -- Ultra–Long-Distance Robotic-Assisted Subretinal Injection for Submacular Hemorrhage
2. Retinal Physician — Flow Mechanics of Suprachoroidal Injection
3. Retinal Physician — Improving Durability of Drugs in Wet AMD
4. Ophthalmology Management — Comprehensive Ophthalmologists Should Do Intravitreal Injections
5. retinal physician — A Suprachoroidal Route to Retinal Therapy
6. Management of Submacular Hemorrhage - EyeWiki
7. Ultra–Long-Distance Robotic-Assisted Subretinal Injection for Submacular Hemorrhage | Surgery | JAMA Ophthalmology | JAMA Network